Literature DB >> 3497662

Effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on blast progenitors from acute myeloblastic leukaemia patients.

N Nara, I Murohashi, T Suzuki, Y Yamashita, Y Maruyama, N Aoki, S Tanikawa, Y Onozawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3497662      PMCID： PMC2001683          DOI： 10.1038/bjc.1987.151

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  13 in total

Review 1.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

2.  Colony assay for proliferative blast cells circulating in myeloblastic leukaemia.

Authors:  R N Buick; J E Till; E A McCulloch
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

3.  Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia.

Authors:  R N Buick; M D Minden; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

4.  Production of leukemic blast growth factor by a human bladder carcinoma cell line.

Authors:  T Hoang; E A McCulloch
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

5.  The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia.

Authors:  N Nara; E A McCulloch
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

6.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia.

Authors:  K D Sabbath; E D Ball; P Larcom; R B Davis; J D Griffin
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia.

Authors:  T Hoang; N Nara; G Wong; S Clark; M D Minden; E A McCulloch
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

8.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

9.  The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML).

Authors:  E A McCulloch; J E Curtis; H A Messner; J S Senn; T P Germanson
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

10.  Comparison between agar and methylcellulose cultures of human leukemic cells.

Authors:  K Kubota; H D Preisler; K Sagawa; J Minowada
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701
View more
  8 in total

Review 1.  G-CSF: status quo and new indications.

Authors:  F Herrmann
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

2.  Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines.

Authors:  K E Cha; S Y Yoon; K N Lee
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 3.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

4.  Combined antitumor effects of TNF and G-CSF on a human medulloblastoma xenograft line.

Authors:  H Maeda; T Uozumi; K Kurisu; T Matsuoka; K Kawamoto; K Kiya; H Ogasawara; K Sugiyama; T Mikami; S Monden
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.

Authors:  T Suzuki; T Morio; S Tohda; K Nagata; Y Yamashita; Y Imai; N Aoki; K Hirashima; N Nara
Journal:  Jpn J Cancer Res       Date:  1990-10

6.  Hematologic and cytogenetic findings in myelodysplastic syndromes treated with recombinant human granulocyte colony-stimulating factor.

Authors:  K Ohyashiki; J H Ohyashiki; K Toyama; F Takaku
Journal:  Jpn J Cancer Res       Date:  1989-09

7.  Effect of recombinant human D-factor on the growth of leukemic blast progenitors from acute myeloblastic leukemia patients.

Authors:  G J Chen; M Tomida; M Hozumi; N Nara
Journal:  Jpn J Cancer Res       Date:  1992-12

8.  Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial.

Authors:  Lei Gao; Yanqi Zhang; Sanbin Wang; Peiyan Kong; Yi Su; Jiong Hu; Ming Jiang; Hai Bai; Tao Lang; Jishi Wang; Li Liu; Tonghua Yang; Xiaobing Huang; Fang Liu; Shifeng Lou; Yao Liu; Cheng Zhang; Hong Liu; Li Gao; Jia Liu; Lidan Zhu; Qin Wen; Ting Chen; Ping Wang; Jun Rao; Min Mao; Cunbang Wang; Xianlin Duan; Le Luo; Xiangui Peng; Kaniel Cassady; Jiang F Zhong; Xi Zhang
Journal:  J Clin Oncol       Date:  2020-10-27       Impact factor: 44.544
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.